PBPHvsETF 2ETF Comparison
ETF 1
PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
This fund is part of
DM Large & Mid Cap
-0.57%
VS
Choose a second ETF to run a side-by-side ETF comparison with PBPH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBPH ETF 2 | -1.83%– | -5.37%– | -2.73%– | n/a– | n/a– | n/a– |
| Flows | PBPH ETF 2 | +$39M– | +$757M– | +$787M– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBPH ETF 2 | +16.32%– | n/a– | n/a– | n/a– |
| Max drawdown | PBPH ETF 2 | -9.94%– | n/a– | n/a– | n/a– |
| Max drawdown duration | PBPH ETF 2 | 70d– | n/a– | n/a– | n/a– |
Trading data
PBPH | ETF 2 | |
Last sale 4/30/2026 at 7:33 PM | $25.06 | – |
| Previous close 04/29/2026 | $24.30 | – |
| Consolidated volume 04/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBPH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/30/2026 at 7:33 PM
Live
Closed
PBPH | ETF 2 | |
|---|---|---|
| Last price | $25.06 | – |
| 1D performance | +3.14% | – |
| AuM | $725.81 M | – |
| E/R | 0.13% | – |
Characteristics
PBPH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Tidal | – |
| Benchmark | BITA Global Pharma and Biotech Select Index | – |
| N° of holdings | 49 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 24, 2025 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PBPH
USA
63.05%
Switzerland
10.48%
Other
26.47%
ETF 2
Sectors
PBPH
Health Care
85.65%
Other
14.35%
ETF 2
Advertisement
Diversification
PBPH
Total weight of top 15 holdings out of 15
71.34%
ETF 2
–
Top 15 holdings
Data as of March 31, 2026
PBPH
LILLY
12.31%
JOHNSON&JOHNSON
9.59%
ABBVIE
6.19%
MERCK & CO INC
4.79%
NOVARTIS
4.64%
CH1499059983
4.47%
GILEAD SCIENCES
4.42%
AMGEN-T
4.38%
PFIZER
4.13%
BRISTOL-MYERS SQUIBB
3.18%
DK0062498333
2.96%
VERTEX PHARMACEUTICALS
2.94%
SANOFI SA
2.68%
GSK PLC
2.67%
REGENERON PHARMACEUTICALS
2.00%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
